AICAR CAS:2627-69-2
AICAR (Acadesine) Applicationem corporis aedificandi magni momenti est inquisitio pharmacologicae agentis, principaliter ut in AMK activator. Compositum est, quod in animalibus laboratorios effectus ostendit gravissimos pingues iacturae et patientiae amplificandae. Quae quidem, AICAR operatur optima pars patientiae ACERVUS, et adhibitum est ab athletis sicut effectus crevit in compositis ludis, ubi …
Andarine CAS:401900-40-1
Andarine S4 is a Selective Androgen Receptor Modulator (SARM) developed per GTx *. Like all SARM’s S4 was developed in the treatment of muscle wasting diseases with benign prostatic hypertrophy treatment also being high on the list of possible treatment benefits. Andarine is not as strong as some of the other SARM’s in terms of an anabolic effect that leads to …
Sunifiram CAS:314728-85-3
Sunifiram (DM-235) Est synthetica derivatio Piracetam, quamquam ex pyrrolidone spinarum fractura iam non est in Racetam medicamentorum genere (tamen ab eis, est etiam commune cum hoc genere). Sunifiram Applications: Sunifiram est unus ex ultimis nootropicis in mercatu ad medicamentorum callidorum familiam. Consideratum est …
LGD-3303 CAS:917891-35-1
LGD-3303 sicut LG121071, erat developed per Ligand Pharmaceuticals. Structura chemica LGD-3303 similis est quam LGD-4033, alterum SARM evolvit Ligand Pharmaceuticals.LGD 3303 NON Anamorelin. Potentissimum est SARM personaliter modernum vidimus! LGD 3303 – Most Anabolic SARMs pulveris? Multa confusione circa LGD fuit 3303 esse ad incrementum hormone …
LGD-4033 CAS:1165910-22-4
LGD-4033 (Ligandrol) nova est oralis non-steroidalis SARM quae cum AR affinitate summa ligat (Ki of ~1 nM) ac selectivity. Est in genere androgeni receptoris (AR) ligands id est TEXTUS selectivam, vastitas cum musculus cancer developed tractare, acutus et longus morbus et musculus damnum vetustate relatas. LGD-4033 (Ligandrol) expectat ad producendum therapeutica beneficia …
YK11 CAS:1370003-76-1
Descriptiones de YK11 YK-11 synthetica est, steroidal electrix androgen receptor modulator (SARM). Est gene-selectivum partialis agonist androgeni receptoris (AR) et non inducit physicam commercium inter NTD/AF1 et LBD/AF2 (quae N / C commercium), quod requiritur ad plenam transactionem AR .. Medicatum est actio anabolica in vitro in myoblasts C2C12 …
RAD-140 CAS:1182367-47-0
RAD140 (Testolone) Descriptio: RAD140 est valde efficax, oralis SARM currently studeatur tam effectus anabolicis et neuroprotective. Est in genere androgen receptor (AR) ligands quae sunt TEXTUS selectivam, vastitas cum musculus cancer developed tractare, acutus et longus morbus et musculus damnum vetustate relatas. Recentes investigationes RAD140 textus macilentiæ selectivity superiores ostendit, et deiectus …
GW-0742 CAS:317318-84-6
GW0742 valde selectivam et potentem PPAR della agonist. Currently venditum est ad investigationes proposita sub licentia ex GlaxoSmithKline. PPAR della agonistae receptae nuclei sunt servo nuclei qui partes criticas exercent in metabolismo humano moderando., cellula progressionem, et cellula differentia. Product Function reduces Gut Inflammatio Improves Cordis Health adiuvat diabete amplio Lipid Profile prohibet Hypertension
GW-501516 CAS:317318-70-0
Basic Information about Cardarine Endurobol GW-501516 GW501516 (also known as GW-501,516, GW1516, GSK-516 et Endurobol, receptor agonist PPARδ inventus est in collaboratione inter Ligand pharmaceutica et glaxoSmithKline in 1990s, ingressus est in orci evolutionem tamquam medicamentum candidatum morborum metabolicorum et morborum cardiovascularium, ac relictum est 2007 quia animal probatio ostendit quod …
SR9011 CAS:1379686-29-9
SR9011 potens est ac specifica synthetica REV-ERB agonista, quae obligat ad REV-ERB-α cum EC50 ~ 790 nM et REV-ERB-β cum EC50 ~ 560 nM.. Etiam in vivo plasma bonum habet/expositio cerebri. Receptores nuclei REV-ERB-α et REV-ERB-β partes integrales agunt in moderandis expressionis core horologii servo., driving rhythmi in actione et metabolismi. Administration of SR9011 alterat …
SR9009 CAS:1379686-30-2
Beneficia SR9009 promovet ligamentorum sanationem, tendinum, ossium ac veteres iniurias Laesiones laxas cutem ad obstringere Promovet massa musculi macris oxidatio pinguium auget SR9009: Venenum ut maiorem Breakthrough in Opportunitas Causare Medicamentum a Professore Thoma Burris evoluta est, qui invenit capacem adips minuendi in exemplaribus animalibus, praecipue …
MK-1775 CAS:955365-80-7
Quid MK, MDCCLXXV? MK, MDCCLXXV est inhibitor in LAPIS Kinase Wee1 (Ic50 = 5.2 NM).1 Hoc est ostensum est inhibere phosphorylation Cdc2 ad Tryosine, XV, Quod abrogat G2 DNA Damnum Checkpoint.1 in P53, deficiens tumores, qui confidunt solely in G2 LAPIS in DNA Damnum, MK, MDCCLXXV, In tandem cum DNA-Damaging Chemotherapeutica Agentibus, relatum est ut apoptosis …